Zhejiang Tailin BioEngineering Co.,Ltd (300813.SZ)
CNY 18.76
(-0.11%)
CNY 18.76
(-0.11%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 323.26 Million CNY | 17.46% |
| 2022 | 275.2 Million CNY | 73.64% |
| 2021 | 158.49 Million CNY | 65.53% |
| 2020 | 95.74 Million CNY | 153.27% |
| 2019 | 37.8 Million CNY | -37.43% |
| 2018 | 60.41 Million CNY | 28.27% |
| 2017 | 47.1 Million CNY | 18.77% |
| 2016 | 39.65 Million CNY | 17.37% |
| 2015 | 33.79 Million CNY | 44.71% |
| 2014 | 23.35 Million CNY | 36.89% |
| 2013 | 17.05 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 306.48 Million CNY | 2.57% |
| 2024 Q1 | 288.04 Million CNY | -10.9% |
| 2024 Q2 | 298.81 Million CNY | 3.74% |
| 2023 Q4 | 323.26 Million CNY | 4.97% |
| 2023 FY | 323.26 Million CNY | 17.46% |
| 2023 Q1 | 254.2 Million CNY | -7.63% |
| 2023 Q2 | 260.23 Million CNY | 2.37% |
| 2023 Q3 | 307.95 Million CNY | 18.34% |
| 2022 Q4 | 275.2 Million CNY | -16.65% |
| 2022 FY | 275.2 Million CNY | 73.64% |
| 2022 Q2 | 282.17 Million CNY | -1.02% |
| 2022 Q3 | 330.19 Million CNY | 17.02% |
| 2022 Q1 | 285.07 Million CNY | 79.87% |
| 2021 Q2 | 105.81 Million CNY | 13.94% |
| 2021 Q4 | 158.49 Million CNY | 26.21% |
| 2021 FY | 158.49 Million CNY | 65.53% |
| 2021 Q1 | 92.86 Million CNY | -3.01% |
| 2021 Q3 | 125.57 Million CNY | 18.67% |
| 2020 FY | 95.74 Million CNY | 153.27% |
| 2020 Q2 | 54.77 Million CNY | 15.69% |
| 2020 Q4 | 95.74 Million CNY | 57.67% |
| 2020 Q3 | 60.72 Million CNY | 10.86% |
| 2020 Q1 | 47.35 Million CNY | 25.25% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q3 | 41.36 Million CNY | 19.24% |
| 2019 FY | 37.8 Million CNY | -37.43% |
| 2019 Q4 | 37.8 Million CNY | -8.6% |
| 2019 Q2 | 34.69 Million CNY | 0.0% |
| 2018 Q4 | 60.41 Million CNY | 0.0% |
| 2018 FY | 60.41 Million CNY | 28.27% |
| 2017 Q4 | 47.1 Million CNY | 1.88% |
| 2017 Q2 | 37.83 Million CNY | 0.0% |
| 2017 FY | 47.1 Million CNY | 18.77% |
| 2017 Q3 | 46.23 Million CNY | 22.2% |
| 2017 Q1 | 37.83 Million CNY | -3.48% |
| 2016 Q1 | 24.64 Million CNY | -27.07% |
| 2016 Q4 | 39.19 Million CNY | 0.0% |
| 2016 Q3 | 39.19 Million CNY | 59.04% |
| 2016 Q2 | 24.64 Million CNY | 0.0% |
| 2016 FY | 39.65 Million CNY | 17.37% |
| 2015 Q1 | 13.76 Million CNY | -41.07% |
| 2015 Q2 | 13.47 Million CNY | -2.08% |
| 2015 Q3 | 33.79 Million CNY | 150.77% |
| 2015 FY | 33.79 Million CNY | 44.71% |
| 2015 Q4 | 33.79 Million CNY | 0.0% |
| 2014 Q3 | 23.35 Million CNY | 0.0% |
| 2014 FY | 23.35 Million CNY | 36.89% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q4 | 23.35 Million CNY | 0.0% |
| 2013 FY | 17.05 Million CNY | 0.0% |